Skip to main content
Previous
Poster Home
Next
Rhenium(RE-186) Obisbemeda{RE-186 nanoliposome (186RNL)}in Leptomeningeal Metastasis [LM] Phase 1/2A Dose Escalation Trial: Update of Initial Safety and Feasibility Through Cohorts 1-4
07:30am - 03:35pm EST - April 5, 2024
Information
Resources
Abstract: JNCCN23-0773
https://jnccn.org/view/journal...
Author(s):
Norman LaFrance, MD
, PLUS Therapeutics
Tags:
Trials in Progress
Display Label
Action